MAM
MPM Asset Management Portfolio holdings
AUM
$43.3M
This Quarter Return
+7.89%
1 Year Return
-54.44%
3 Year Return
+14.05%
5 Year Return
-29.8%
10 Year Return
-11.6%
AUM
$243M
AUM Growth
+$243M
(+105%)
Cap. Flow
+$111M
Cap. Flow
% of AUM
45.86%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
2
Increased
–
Reduced
–
Closed
1
Top Buys
| 1 |
TCRR
TCR2 Therapeutics Inc. Common Stock
TCRR
|
$70.6M |
| 2 |
HARP
Harpoon Therapeutics, Inc. Common Stock
HARP
|
$42.8M |
Top Sells
| 1 |
Protara Therapeutics
TARA
|
$2.23M |
Sector Composition
| 1 | Healthcare | 99.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Rhythm Pharmaceuticals
RYTM
$6.85B
| $84.3M | 34.75% | 3,074,893 | – | – |
|
|
TCRR
2
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $70.6M | 29.11% | +4,050,865 | New | +$70.6M |
|
|
HARP
3
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $42.8M | 17.67% | +4,524,425 | New | +$42.8M |
|
|
CHMA
4
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $29.8M | 12.3% | 5,736,296 | – | – |
|
5
Syndax Pharmaceuticals
SNDX
$1.41B
| $11.4M | 4.7% | 2,168,691 | – | – |
|
|
HSTO
6
DELISTED
Histogen Inc. Common Stock
HSTO
| $2.66M | 1.1% | 2,464,807 | – | – |
|
|
PETX
7
DELISTED
Aratana Therapeutics, Inc.
PETX
| $900K | 0.37% | 250,000 | – | – |
|
|
8
Protara Therapeutics
TARA
$120M
| – | – | -983,381 | Closed | -$2.23M |
|